Renaissance Technologies’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-118
| Closed | -$170K | – | 4014 |
|
|
2022
Q2 | $170K | Sell |
118
-9
| -7% | -$13K | ﹤0.01% | 3707 |
|
|
2022
Q1 | $266K | Buy |
127
+113
| +807% | +$237K | ﹤0.01% | 3522 |
|
|
2021
Q4 | $68K | Buy |
14
+4
| +40% | +$19.4K | ﹤0.01% | 3748 |
|
|
2021
Q3 | $61K | Buy |
+10
| New | +$61K | ﹤0.01% | 3364 |
|
|
2021
Q2 | – | Sell |
-99
| Closed | -$860K | – | 3445 |
|
|
2021
Q1 | $860K | Buy |
99
+62
| +168% | +$539K | ﹤0.01% | 2669 |
|
|
2020
Q4 | $284K | Sell |
37
-32
| -46% | -$246K | ﹤0.01% | 3052 |
|
|
2020
Q3 | $451K | Sell |
69
-99
| -59% | -$647K | ﹤0.01% | 2846 |
|
|
2020
Q2 | $1.26M | Buy |
+168
| New | +$1.26M | ﹤0.01% | 2433 |
|
|
2019
Q3 | – | Sell |
-12
| Closed | -$181K | – | 3421 |
|
|
2019
Q2 | $181K | Buy |
+12
| New | +$181K | ﹤0.01% | 3320 |
|